Teresa C. Dugger
- Oncology top 1%
- HER2/EGFR in Cancer Research 7
- Cancer Cells and Metastasis 6
- Cancer Research top 5%
- Immunology and Allergy top 5%
- Cell Adhesion Molecules Research 3
- Molecular Biology top 5%
- TGF-β signaling in diseases 9
- Metabolism, Diabetes, and Cancer 3
-
- Monoclonal and Polyclonal Antibodies Research 7
- Radiopharmaceutical Chemistry and Applications 3
-
- Growth Hormone and Insulin-like Growth Factors 3
- Co-authors
- Carlos L. ArteagaChristoph A. RitterMarta GuixCammie RinehartVioleta SánchezMelinda E. SandersRebecca S. MuraokaNancy Dumont
- Journals
- Journal of Biological Chemistry (1 paper)Journal of Clinical Investigation (5 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Teresa C. Dugger
22 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Oncology 1.7k
- Cancer Research 503
- Immunology and Allergy 153
- Molecular Biology 1.7k
- Radiology, Nuclear Medicine and Imaging 388
Countries citing papers authored by Teresa C. Dugger
This map shows the geographic impact of Teresa C. Dugger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teresa C. Dugger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teresa C. Dugger more than expected).
Fields of papers citing papers by Teresa C. Dugger
This network shows the impact of papers produced by Teresa C. Dugger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teresa C. Dugger. The network helps show where Teresa C. Dugger may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Teresa C. Dugger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 1 | |
| 2 | 2017 | 171 | |
| 3 | 2017 | 35 | |
| 4 | 2014 | 50 | |
| 5 | TGF-β inhibition enhances chemotherapy action against triple-negative breast cancerbreakdown → | 2013 | 475 |
| 6 | 2012 | 1 | |
| 7 | 2009 | 99 | |
| 8 | 2007 | 290 | |
| 9 | 2007 | 388 | |
| 10 | HER2/neu (erbB2) kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGF receptors | 2006 | 1 |
| 11 | 2004 | 11 | |
| 12 | 2004 | 110 | |
| 13 | 2002 | 410 | |
| 14 | 2002 | 365 | |
| 15 | 2002 | 14 | |
| 16 | 1999 | 61 | |
| 17 | 1997 | 34 | |
| 18 | 1996 | 43 | |
| 19 | Ligand-like effects induced by anti-c-erbB-2 antibodies do not correlate with and are not required for growth inhibition of human carcinoma cells. | 1994 | 28 |
| 20 | 1993 | 22 |
About Teresa C. Dugger
Teresa C. Dugger is a scholar working on Oncology, Immunology and Allergy and Radiology, Nuclear Medicine and Imaging, having authored 22 papers that have together received 2.7k indexed citations. Recurring topics across this work include TGF-β signaling in diseases (9 papers), HER2/EGFR in Cancer Research (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Cancer Cells and Metastasis (6 papers), Radiopharmaceutical Chemistry and Applications (3 papers), Growth Hormone and Insulin-like Growth Factors (3 papers), Cell Adhesion Molecules Research (3 papers) and Metabolism, Diabetes, and Cancer (3 papers). The work is most often cited by research in Oncology (1.7k citations), Cancer Research (503 citations) and Immunology and Allergy (153 citations). Teresa C. Dugger has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Carlos L. Arteaga, Christoph A. Ritter, Marta Guix, Cammie Rinehart, Violeta Sánchez, Melinda E. Sanders, Rebecca S. Muraoka, Nancy Dumont, Dana M. Brantley and Jin Chen. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.